CHARLES STEIN, MD
Osteopathic Medicine in Nashville, TN

License number
Tennessee MD25302
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
3601 Tvc, Nashville, TN 37232
Phone
(615) 322-3000

Organization information

See more information about CHARLES STEIN at bizstanding.com

Charles Stein MD

1005 Dr Db Todd Jr Blvd, Nashville, TN 37208

Industry:
Internist
Phone:
(615) 341-4728 (Phone)
Charles Michael Stein

Professional information

See more information about CHARLES STEIN at trustoria.com
Charles Stein Photo 1
Dr. Charles Stein, Nashville TN - MD (Doctor of Medicine)

Dr. Charles Stein, Nashville TN - MD (Doctor of Medicine)

Specialties:
Rheumatology
Address:
Vanderbilt Medical Center
2200 Pierce Ave SUITE 538, Nashville 37232
(615) 875-3049 (Phone)
Conditions:
Arthritis, Chronic Neck Pain, Fibromyalgia, Gout, Low Back Pain, Osteoarthritis, Osteoarthritis of Knee, Osteoarthritis of Spine, Osteopenia, Osteoporosis, Patellofemoral Pain Syndrome or Knee Pain, Rheumatoid Arthritis, Sjögren's Syndrome, Spondylitis, Systemic Lupus Erythematosus (SLE), Systemic Sclerosis
Languages:
English
Hospitals:
Vanderbilt Medical Center
2200 Pierce Ave SUITE 538, Nashville 37232
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
Education:
Medical School
University Of Cape Town
Graduated: 1978


Charles Stein Photo 2
Charles Stein, Nashville TN

Charles Stein, Nashville TN

Specialties:
Internal Medicine, Rheumatology
Work:
Vanderbilt Medical Group At Bellevue
3601 The Vanderbilt Clinic, Nashville, TN 37232
Education:
University Of Cape Town (1978)


Charles Stein Photo 3
Method For Evaluating Immunosuppressive Regimens

Method For Evaluating Immunosuppressive Regimens

US Patent:
6329153, Dec 11, 2001
Filed:
Jun 22, 1999
Appl. No.:
9/337967
Inventors:
Charles M. Stein - Nashville TN
John J. Murray - Brentwood TN
Alastair J. J. Wood - Brentwood TN
Assignee:
Vanderbilt University - Nashville TN
International Classification:
G01N 3353
US Classification:
435 71
Abstract:
The present invention describes a simple technique that provides a biologically relevant measure of the inhibitory effect of cyclosporine in vivo. This ability to measure response to cyclosporine may improve prediction of the efficacy of immunosuppressive treatment in patients and may allow optimal immunosuppression in individual patients.